Bifurcation Lesions Market Analysis by Application (Coronary Vascular andPeripheral Vascular), by Region (North America, Europe, Asia Pacific, Latin America, MEA) and Segment Forecasts, 2014 - 2025

  • ID: 4396377
  • Report
  • Region: America, Asia, Asia Pacific, Europe, North America, United States
  • 90 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Abbott
  • C. R. Bard, Inc.
  • Cardinal Health
  • Medtronic
  • Spectranetics
  • MORE
The global bifurcation lesions market is expected to reach USD 2.8 billion by 2025, growing at a CAGR of 5.6%. Technological developments and supportive government initiatives for reimbursement are likely to drive the market during the forecast period.

Increasing geriatric population and unhealthy lifestyle are responsible for growth in incidence of cardiovascular disorders. Furthermore, increase in approval & commercialization of innovative devices and expected entry of new devices for treatment of bifurcation lesions in the coming years are likely to drive the market.

In addition, rising affordability, increase in demand for minimally invasive procedures, and growing medical tourism are also boosting demand for bifurcation lesions procedures across the globe. According to various studies, procedures for coronary bifurcation lesions comprise approximately 20% of total percutaneous coronary interventions.

Further key findings from the report suggest:
  • Increase in commercialization of devices for bifurcation lesions and investments by industry players for R&D are expected to boost the market, resulting in an anticipated CAGR of around 5% from 2017 to 2025
  • Coronary vascular segment accounted for maximum share of the market in 2016 due to presence of complex vascular network in heart, increased availability of devices, and rise in awareness regarding surgical interventions for bifurcation lesions.
  • Peripheral vascular segment is likely to witness lucrative growth in the coming years due to increase in investments by industry players for development of devices for peripheral application and advancements in diagnostics facilitating accurate detection of plaque.
  • Geographically, North America held the largest share of the bifurcation lesions market in 2016. It is anticipated to maintain its dominance in the coming years due to increasing demand for drug-eluting stents, commercialization of devices for bifurcation lesions, and local presence of major market players.
  • Asia Pacific is expected to observe fastest growth over the next decade owing to improvement in healthcare infrastructure, medical tourism, and rise in investments by market players in the region.
  • Some of the key players in the market are Abbott; Boston Scientific Corporation; Cardinal Health; Medtronic; Johnson & Johnson Services, Inc.; C. R. Bard, Inc.; Spectranetics; and Terumo Medical Corporation. Tryton Medical, Inc. developed Tryton Side Branch Stent with a balloon-expandable, single-wire stent delivery system that can be deployed in the side branch artery for treatment of bifurcation lesions. The device is available in the U.S. and Europe as well as Middle East & Africa.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • C. R. Bard, Inc.
  • Cardinal Health
  • Medtronic
  • Spectranetics
  • MORE
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Snapshot

Chapter 3. Bifurcation Lesions Market Industry Outlook
3.1. Market Segmentation
3.2. Market Size and Growth Prospects, 2014 - 2025
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Key Opportunities Prioritized
3.5. Industry Analysis - Porter's
3.6. PESTLE Analysis, 2016
3.7. Bifurcation Lesions Competitive Scenario, 2016
3.7.1. Competitive landscape/Heat map analysis: Market position analysis (based on product portfolio, regional presence and strategic initiatives)

Chapter 4. Bifurcation Lesions Market: Application Outlook
4.1. Bifurcation Lesions Market Share by Application, 2016 & 2025 (USD Million)
4.2. Coronary Vascular
4.2.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.2. Market estimates and forecasts by region, 2014 - 2025 (USD Million)
4.3. Peripheral Vascular
4.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
4.3.2. Market estimates and forecasts by region, 2014 - 2025 (USD Million)

Chapter 5. Bifurcation Lesions Market: Regional Outlook
5.1. Bifurcation Lesions Market Share by Region, 2016& 2025(USD Million)
5.2. North America
5.2.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
5.2.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
5.2.3. U.S.
5.2.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
5.2.3.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
5.2.4. Canada
5.2.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
5.2.4.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
5.3. Europe
5.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
5.3.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
5.3.3. Germany
5.3.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
5.3.3.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
5.3.4. U.K.
5.3.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
5.3.4.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
5.4. Asia Pacific
5.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
5.4.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
5.4.3. Japan
5.4.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
5.4.3.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
5.4.4. China
5.4.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
5.4.4.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
5.5. Latin America
5.5.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
5.5.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
5.5.3. Brazil
5.5.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
5.5.3.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
5.5.4. Mexico
5.5.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
5.5.4.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
5.6. Middle East & Africa
5.6.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
5.6.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)
5.6.3. South Africa
5.6.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
5.6.3.2. Market estimates and forecasts by application, 2014 - 2025 (USD Million)

Chapter 6. Competitive Landscape
6.1. Competitive Environment
6.2. Strategy Framework

Chapter 7. Company Profiles
7.1. Medtronic
7.1.1. Company overview
7.1.2. Financial performance
7.1.3. Product benchmarking
7.1.4. Strategic initiatives
7.2. Boston Scientific Corporation
7.2.1. Company overview
7.2.2. Financial performance
7.2.3. Product benchmarking
7.2.4. Strategic initiatives
7.3. Johnson& Johnson Services, Inc
7.3.1. Company overview
7.3.2. Financial performance
7.3.3. Product benchmarking
7.3.4. Strategic initiatives
7.4. Abbott
7.4.1. Company overview
7.4.2. Financial performance
7.4.3. Product benchmarking
7.4.4. Strategic initiatives
7.5. C. R. Bard, Inc.
7.5.1. Company overview
7.5.2. Financial performance
7.5.3. Product benchmarking
7.5.4. Strategic initiatives
7.6. Spectranetics
7.6.1. Company overview
7.6.2. Financial performance
7.6.3. Product benchmarking
7.6.4. Strategic initiatives
7.7. Terumo Medical Corporation
7.7.1. Company overview
7.7.2. Financial performance
7.7.3. Product benchmarking
7.7.4. Strategic initiatives
7.8. Cardinal Health
7.8.1. Company overview
7.8.2. Financial performance
7.8.3. Product benchmarking
7.8.4. Strategic initiatives

List of Tables
Table 1 Bifurcation lesionsmarket estimates and forecast by application, 2014 - 2025 (USD Million)
Table 2 Bifurcation lesionsmarket estimates and forecast by region, 2014 - 2025 (USD Million)
Table 3 North America bifurcation lesion market estimates and forecast by country, 2014 - 2025 (USD Million)
Table 4 North America bifurcation lesion market estimates and forecast by application, 2014 - 2025 (USD Million)
Table 5 U.S. bifurcation lesionmarket estimates and forecast by application (USD Million)
Table 6 Canada bifurcation lesionmarket estimates and forecast by application (USD Million)
Table 7 Europe bifurcation lesionmarket estimates and forecast by country, 2014 - 2025 (USD Million)
Table 8 Europe bifurcation lesion market estimates and forecast by application, 2014 - 2025 (USD Million)
Table 9 Germany bifurcation lesionmarket estimates and forecast by application, 2014 - 2025 (USD Million)
Table 10 U.K. bifurcation lesion market estimates and forecast by application (USD Million)
Table 11 Asia Pacific bifurcation lesion market estimates and forecast by country, 2014 - 2025 (USD Million)
Table 12 Asia Pacific bifurcation lesion market estimates and forecast by application, 2014 - 2025 (USD Million)
Table 13 Japan bifurcation lesion market estimates and forecast by application, 2014 - 2025 (USD Million)
Table 14 China bifurcation lesion market estimates and forecast by application (USD Million)
Table 15 Latin America bifurcation lesion market estimates and forecast by country, 2014 - 2025 (USD Million)
Table 16 Latin America bifurcation lesion market estimates and forecast by application, 2014 - 2025 (USD Million)
Table 17 Brazil bifurcation lesion market estimates and forecast by application, 2014 - 2025 (USD Million)
Table 18 Mexico bifurcation lesion market estimates and forecast by application (USD Million)
Table 19 Middle East & Africa bifurcation lesion market estimates and forecast by country, 2014 - 2025 (USD Million)
Table 20 Middle East & Africa bifurcation lesion market estimates and forecast by application, 2014 - 2025 (USD Million)
Table 21 South Africa bifurcation lesion market estimates and forecast by application (USD Million)

List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain based sizing &forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Bifurcation lesions market summary 2016 (USD Million)
Figure 8 Market trends & outlook
Figure 9 Market segmentation & scope
Figure 10 Market driver relevance analysis (Current & future impact)
Figure 11 Market restraint relevance analysis (Current & future impact)
Figure 12 Penetration & growth prospect mapping
Figure 13 SWOT Analysis, by factor (political & legal, economic and technological)
Figure 14 Porter’s Five Forces analysis
Figure 15 Bifurcation lesions competitive landscape: Market position analysis (based on procedures, regional presence)
Figure 16 Bifurcation lesions market, application outlook key takeaways
Figure 17 Bifurcation lesions application movement analysis
Figure 18 Coronary vascular bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 19 Peripheral vascular bifurcation lesions market, 2014 - 2024 (USD Million)
Figure 20 Regional market place: Key takeaways
Figure 21 Bifurcation lesions market: Regional movement analysis
Figure 22 North America bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 23 The U.S. bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 24 Canada bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 25 Europe bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 26 Germany bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 27 The UK bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 28 Asia Pacific bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 29 Japan bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 30 China bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 31 Latin America bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 32 Brazil bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 33 Mexico bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 34 MEA bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 35 South Africa bifurcation lesions market, 2014 - 2025 (USD Million)
Figure 36 Competitive strategy adopted by leading players
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health
  • Johnson& Johnson Services, Inc
  • Medtronic
  • Spectranetics
  • Terumo Medical Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll